Literature DB >> 17080266

TSH adenomas.

Edward R Laws1, Mary Lee Vance, John A Jane.   

Abstract

Thyrotropin (TSH) adenomas are uncommon tumors of the anterior pituitary. Clinically, they may present with hyperthyroidism, hypothyroidism, hypopituitarism, or visual loss. Proper diagnosis requires appropriate neuroendocrine evaluation. Although transsphenoidal surgery remains the first-line treatment, adjuvant medical therapy is frequently required for these often invasive tumors. Radiotherapy or radiosurgery should be considered for those patients with persistent TSH hypersecretion following surgery and medical therapy. The clinical evaluation and treatment algorithm for patients with TSH adenomas is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080266     DOI: 10.1007/s11102-006-0411-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  8 in total

1.  Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurosurg       Date:  2000-08       Impact factor: 5.115

Review 2.  Thyrotropin-secreting pituitary tumors.

Authors:  P Beck-Peccoz; F Brucker-Davis; L Persani; R C Smallridge; B D Weintraub
Journal:  Endocr Rev       Date:  1996-12       Impact factor: 19.871

3.  Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients.

Authors:  M Bertholon-Grégoire; J Trouillas; M P Guigard; B Loras; J Tourniaire
Journal:  Eur J Endocrinol       Date:  1999-06       Impact factor: 6.664

4.  Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.

Authors:  P Caron; S Arlot; C Bauters; P Chanson; J M Kuhn; M Pugeat; R Marechaud; C Teutsch; E Vidal; P Sassano
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

5.  Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health.

Authors:  F Brucker-Davis; E H Oldfield; M C Skarulis; J L Doppman; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

6.  Thyrotropin-producing pituitary adenomas.

Authors:  T Mindermann; C B Wilson
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

7.  Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.

Authors:  Akira Teramoto; Naoko Sanno; Shigeyuki Tahara; Yoshiyuki R Osamura
Journal:  Acta Neuropathol       Date:  2004-06-05       Impact factor: 17.088

8.  The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.

Authors:  H Valdes Socin; P Chanson; B Delemer; A Tabarin; V Rohmer; J Mockel; A Stevenaert; A Beckers
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664

  8 in total
  1 in total

1.  Thyrotropin-secreting pituitary adenomas: diagnosis and management of patients from one Chinese center.

Authors:  Weiwei Zhao; Hongying Ye; Yiming Li; Linuo Zhou; Bin Lu; Shuo Zhang; Jie Wen; Shiqi Li; Yehong Yang; Renming Hu
Journal:  Wien Klin Wochenschr       Date:  2012-10-10       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.